iGAS without emm1/T1, n = 25 | iGAS with emm1/T1, n = 25 | p valuea | |
---|---|---|---|
Origin of infection | |||
Soft tissue | 11 (44) | 18 (72) | 0.08 |
Necrotizing fasciitis | 7 (28) | 12 (48) | 0.24 |
Pneumonia | 3 (12) | 3 (12) | 1.00 |
Puerperal | 2 (8.0) | 0 | 0.49 |
Arthritis | 4 (16) | 0 | 0.11 |
Pharyngeal/parapharyngeal | 1 (4.0) | 2 (8.0) | 1.00 |
Mastoiditis | 1 (4.0) | 0 | 1.00 |
Meningitis | 0 | 1 (4.0) | 1.00 |
Unknown focus | 3 (12) | 1 (4.0) | 0.61 |
Septic shock (Sepsis 3)b | 11 (44) | 10 (40) | 1.00 |
IVIGc | 7 (28) | 13 (52) | 0.15 |
DAFd vasopressor | 26 (25–28) | 25 (23–26) | 0.036* |
DAFd ventilation | 26 (20–28) | 24 (20–26) | 0.23 |
CRRTe | 4 (16) | 8 (32) | 0.32 |
AKIN-creaf | 0 (0–3) | 3 (0–3) | 0.007* |
SOFA maxg | 9 (6–13) | 12 (7–14) | 0.11 |
Length of stay, survivors | 2.7 (1.2–4.7) | 5.1 (2.3–7.5) | 0.08 |
SAPS 3h | 65 (54–70) | 61 (58–78) | 0.27 |
EMRi | 28 (11–39) | 21 (15–54) | 0.27 |
ICUj mortality | 2 (8.0) | 1 (4.0) | 1.00 |
28-day mortality | 5 (20) | 1 (4.0) | 0.19 |
90-day mortality | 6 (24) | 2 (8.0) | 0.25 |
180-day mortality | 8 (32) | 3 (12) | 0.17 |